Repurposing anthelmintic agents to eradicate resistant leukemia
Caterina Mezzatesta(University Children's Hospital Zurich), Beat Bornhäuser(University Children's Hospital Zurich), Denis M. Schewe(Klinik und Poliklinik für Kinder- und Jugendmedizin), Martin Schrappe(University Hospital Schleswig-Holstein), Franco Locatelli(Bambino Gesù Children's Hospital), Blerim Marovca(University Children's Hospital Zurich), Silvia Jenni(University Children's Hospital Zurich), Luciana Vinti(Bambino Gesù Children's Hospital), Gunnar Cario, Jean‐Pierre Bourquin(University Children's Hospital Zurich), Júlia Aguadé-Gorgorió(University of California, Los Angeles), Liridon Abduli(University Children's Hospital Zurich), Markéta Žaliová(Novartis (Switzerland)), Arend von Stackelberg(Charité - Universitätsmedizin Berlin), Cornelia Eckert(Humboldt-Universität zu Berlin), Anna Guinot(University Children's Hospital Zurich), Yi-Chien Tsai(University Children's Hospital Zurich), Martin Stanulla(Leibniz University Hannover)
Cited by 8
Related Papers
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
|The Lancet|1998|964
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738